tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Hologic price target raised to $69 from $65 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Hologic (HOLX) to $69 from $65 and keeps an Equal Weight rating on the shares following “solid” revenue and EPS beats for the quarter along with FY25 guidance being raised for the Q3 beat, foreign exchange and M&A contribution.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1